Parker Waichman LLP

FDA Forces New Labeling for Procrit, Aranesp and Epogen

Federal regulators have decided that the anemia drugs Aranesp, Epogen and Procrit need to have additional safety-related changes to their labels.  The changes mandated by  the Food & Drug Administration (FDA)  would restrict the use of the drugs in some cancer patients. Procrit, Aranesp and Epogen are known as erythropoiesis-stimulating agent (ESA).  All are made […]

Federal regulators have decided that the anemia drugs<"https://www.yourlawyer.com/topics/overview/aranesp"> Aranesp, <"https://www.yourlawyer.com/topics/overview/epogen">Epogen and <"https://www.yourlawyer.com/topics/overview/procrit">Procrit need to have additional safety-related changes to their labels.  The changes mandated by  the Food & Drug Administration (FDA)  would restrict the use of the drugs in some cancer patients.

Procrit, Aranesp and Epogen are known as erythropoiesis-stimulating agent (ESA).  All are made by Amgen, but Procrit is sold by Johnson & Johnson subsidiary Ortho Biotech under a licensing agreement. ESAs are a bioengineered version of a natural protein made in the kidney that stimulates the bone marrow to produce more red blood cells. When Procrit was first approved in 1989, the drug was touted as a treatment to lessen fatigue and improve quality of life among cancer and HIV patients with anemia. But since then Procrit has been forced to undergo five label changes, and the label now states that there was no evidence to back that claim.

This past March, Amgen and Johnson & Johnson announced that they would be including another black box warning on the drug’s labels.  The black box warned of the medications’ association with increased tumor growth and shortened survival time in some cancer patients.  The warning came on the heels of the PREPARE breast cancer study. That breast cancer study was one of 5 clinical trials that Amgen had agreed to after the safety of Aranesp was called into question.  PREPARE showed patients had a higher risk of death on Aranesp.  The warning also noted danger for patients with cervical cancer, based on results in December from a study called GOG-191.

That same month, an FDA advisory panel recommended new limits be placed on the drugs.  Yesterday’s announcement that the agency was requiring further label changes and restrictions is the first time FDA using authority granted to it in 2007 to force a drug maker to change a drug’s label.   Apparently, the FDA and Amgen were not able to reach agreement over the label changes.  According to The New York Times, Amgen had wanted the label to give doctors discretion to initiate therapy before hemoglobin levels dropped to 10 in patients who could not tolerate that degree of anemia. And it wanted mention of the 12 gram upper limit for stopping therapy.

The new label will say that say that the drugs shouldn’t be used in cancer patients receiving chemotherapy when a cure of their cancer is anticipated.  The FDA also ordered inclusion of a statement that the drugs aren’t to be administered when hemoglobin levels are greater than or equal to 10 grams per deciliter. Language is being removed that seemed to imply that it was safe to continue treating patients until their hemoglobin rose to 12 grams per deciliter.

Despite the FDA’s tough stance regarding the anemia drug’s, the new labeling does not incorporate all of the recommendations the advisory panel made in March.  The panel had also advised that patients with advanced breast cancer and head-and-neck cancer shouldn’t get the medicines.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
My husband and I could never had gotten through the stress and anxiety of this process without the knowledge and kindness of the Parker Waichman staff but most certainly, not without the help of our paralegal, Christine Morace. She's not only knowledgeable but has been calming and reassuring throughout. Thank you Christine.
Iris Frank
4 years ago
5 Star Reviews 150
I would recommend this firm to others. They were always quick to reply to any of my concerns, especially Shelly. She would answer my emails almost immediately. Highly professional and hassle free.
Kelly Wheeler
3 years ago
5 Star Reviews 150
I have been working for the last 3 years with Tina Morace of Parker Waichman LLP to date and happy to say she handled my case from start to finish diligently. Never had any doubt about her professionalism. If i had questions i knew who to call that is Tina Morace. If i needed an answer she was prompt in delivering her reply and moreso never hesitated in getting in touch with me at all times to let me know how my case is doing. It was a pleasure working with Tina Morace. A very pleasant person to talk to and i would not hesitate to recommend any person who wishes to have their case handled by her. Tina Morace is an asset to Parker Waichman LLP and am proud of her expertise, knowledge and her responsive service of which am proud of her . Thank you Tina Morace for all your help and continued service with Parker Waichman LLP.
Monica Libert
2 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038